This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: Adrenomedullin: a new and promising target for drug discovery

Title Adrenomedullin: a new and promising target for drug discovery
Abstract

Adrenomedullin (AM) is a 52 amino acid peptide that plays a critical role in several diseases such as hypertension, cancer, diabetes, cardiovascular and renal disorders, among others. Interestingly, AM behaves as a protective agent against some pathologies, yet is a stimulating factor for other disorders. Thus, AM can be considered as a new and promising target for the design of non-peptidic modulators that could be useful for the treatment of those pathologies, by regulating AM levels or the activity of AM. A full decade on from its discovery, much more is known about AM molecular biology and pharmacology, but this knowledge still needs to be applied to the development of clinically useful drugs.

Apa Reference García, M.A., Martín-Santamaría, S., de Pascual-Teresa, B., Ramos, A., Julián, M. & Martínez, A. (2006). Adrenomedullin: a new and promising target for drug discovery. Expert Opinion on Therapeutic Targets, 10(2), 303-317. 10.1517/14728222.10.2.303
Doi 10.1517/14728222.10.2.303
Publication Date 21 Mar 2006
Publication Type Article
Researcher Sonsoles Martin Santamaría
Ontology Drug Discovery and design
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home